[1] |
.
Role of Ghrelin in gastric cancer
[J]. Basic & Clinical Medicine, 2024, 44(10): 1460-1464.
|
[2] |
LIU Baoqing, HUANG Rong, LU Yan, LI Kai, ZHANG Ning, LIU Changzheng, SONG Wei.
Progress of gastric cancer organoids in basic research and clinical application
[J]. Basic & Clinical Medicine, 2024, 44(9): 1219-1222.
|
[3] |
HOU Nan, LIU Yuan, GAO Jun, WANG Jing, YUAN Meng.
Whole blood NPM1, MCP-1 and intestinal flora are associated with gastric cancer progression and prognosis
[J]. Basic & Clinical Medicine, 2024, 44(8): 1137-1142.
|
[4] |
YANG Jiaoyang, SHU Gege, LI Dongbao, ZHOU Jin.
Research progress of signaling pathways in gastric cancer metastasis
[J]. Basic & Clinical Medicine, 2023, 43(11): 1707-1712.
|
[5] |
LIU Dong, LI Qingyan, WANG Ziquan, WANG Bingwu, WANG Baoqing.
Detection of miR-34a methylation in peripheral blood of gastric cancer patients and its clinical significance
[J]. Basic & Clinical Medicine, 2023, 43(10): 1572-1576.
|
[6] |
DAI Di, LIU Yuqin.
Diagnostic difficulties and treatment progress of primary gastric lymphoma
[J]. Basic & Clinical Medicine, 2023, 43(9): 1462-1466.
|
[7] |
LI Xun, FU Xiao-xia, FAN Li-wei, WANG Jing-kun, ZHANG Dong-jiao, ZHAO Yan-huan, ZHANG Lei, ZHAO Yu-hong.
Pinocembrin inhibits the proliferation, migration and invasion of gastric cancer cell line AGS
[J]. Basic & Clinical Medicine, 2022, 42(11): 1744-1750.
|
[8] |
CHEN Xi, PANG Hai-yu, QIN Chun-di, GUO Yuan-hong, YANG Ai-ming, LAI Ya-min.
Short-term semi-immersion training based on a learning pyramid model theory can improve the capacity building to find early gastric cancer
[J]. Basic & Clinical Medicine, 2022, 42(4): 696-700.
|
[9] |
NIU Shi-wei, SU Yun, GONG Hong-xia, LI Ting-ting, ZENG Yuan-ding, ZHANG Han, NIE Peng.
Increased serum IL-1 level and activated JAK2/STAT3 signaling pathway of cancer tissue in patients with gastric cancer
[J]. Basic & Clinical Medicine, 2022, 42(3): 401-405.
|
[10] |
LYU Xue, LI Xue-wei, YANG Ting, ZHENG Jin-xiu, ZHU Zi-he, YANG Tao, XU Jun.
Bioinformatic analysis of adenocarcinoma at esophagogastric junction and mutation sites screening of Involucrin gene
[J]. Basic & Clinical Medicine, 2022, 42(2): 235-242.
|
[11] |
HOU Nan, LIU Yuan, GAO Jun, WANG Jing.
miR-141-3p inhibits the migration and invasion of gastric cancer cell line AGS through targeting PDCD1
[J]. Basic & Clinical Medicine, 2021, 41(9): 1297-1302.
|
[12] |
TANG Jia-feng, HE Xue-lian, XIA Jing, XIONG Wei, LI Xiao-shan.
Ursolic acid combined with HDAC2 inhibitor inhibits proliferation of human hepatoma cell line HepG2
[J]. Basic & Clinical Medicine, 2021, 41(8): 1144-1150.
|
[13] |
YANG Yi-li, HE Xue-yuan, PAN Xin-min, MA Jian-xun.
miR-205-5p inhibits the proliferation, migration and invasion of gastric cancer cell lines
[J]. Basic & Clinical Medicine, 2020, 40(8): 1068-1075.
|
[14] |
LI Chun-bo, SU Yun, GONG Hong-xia, XUE Xuan, LI Ting-ting, NIU Shi-wei, NIE Peng.
Immune regulation of IL-17 through NF-κB signaling pathway involved in the development of gastric cancer
[J]. Basic & Clinical Medicine, 2020, 40(7): 923-928.
|
[15] |
YIN Chao-yun, ZHANG Yao, CHEN Zhen-wei, ZHANG An-wei, ZHANG Xuan-feng, ZHANG Ri-ting, BU Xue-feng.
rL-IL29 inhibits proliferation and migration of human gastric cancer cell line BGC
[J]. Basic & Clinical Medicine, 2020, 40(3): 368-373.
|